Table 1. Summary of O-glycosylation of secreted gp120s and gp120+gp140s.
HIV-1 Sample | m/z | Charge | Calculated MW | Peptide | Carbohydrate | Approximate Intensity MS |
---|---|---|---|---|---|---|
YU2 gp120 | 512.9 | 2 | 1023.8 | IEPLGVAPTK | Native peptide | 530 |
695.6 | 2 | 1389.2 | IEPLGVAPTK | HexNAc.Hex | 500 | |
841.1 | 2 | 1680.2 | IEPLGVAPTK | HexNAc.Hex.NeuAc | 200 | |
986.7 | 2 | 1971.4 | IEPLGVAPTK | HexNAc.Hex.NeuAc2 | 2200 | |
1023.7 | 2 | 2045.4 | IEPLGVAPTK | HexNAc2.Hex2.NeuAc | 480 | |
612.6 | 2 | 1223.2 | IEPLGVAPTKAK | Native peptide | Not Observed | |
940.2 | 2 | 1878.4 | IEPLGVAPTKAK | HexNAc.Hex.NeuAc | Not Observed | |
724.2 | 3 | 2169.6 | IEPLGVAPTKAK | HexNAc.Hex.NeuAc2 | Not Observed | |
YU2 gp120+gp140 | 512.7 | 2 | 1023.4 | IEPLGVAPTK | Native peptide | 4940 |
695.2 | 2 | 1388.4 | IEPLGVAPTK | HexNAc.Hex | 2770 | |
840.7 | 2 | 1679.4 | IEPLGVAPTK | HexNAc.Hex.NeuAc | 500 | |
612.6 | 2 | 1223.2 | IEPLGVAPTKAK | Native peptide | 80 | |
940.2 | 2 | 1878.4 | IEPLGVAPTKAK | HexNAc.Hex.NeuAc | 100 | |
724.2 | 3 | 2169.6 | IEPLGVAPTKAK | HexNAc.Hex.NeuAc2 | 60 | |
JRCSF gp120 | 512.7 | 2 | 1023.4 | IEPLGVAPTK | Native peptide | 2000 |
695.3 | 2 | 1388.6 | IEPLGVAPTK | HexNAc.Hex | 1540 | |
840.7 | 2 | 1679.4 | IEPLGVAPTK | HexNAc.Hex.NeuAc | 700 | |
986.4 | 2 | 1970.8 | IEPLGVAPTK | HexNAc.Hex.NeuAc2 | 1360 | |
1023.4 | 2 | 2044.8 | IEPLGVAPTK | HexNAc2.Hex2.NeuAc | 230 | |
612.6 | 2 | 1223.2 | IEPLGVAPTKAK | Native peptide | Not Observed | |
940.2 | 2 | 1878.4 | IEPLGVAPTKAK | HexNAc.Hex.NeuAc | 340 | |
724.2 | 3 | 2169.6 | IEPLGVAPTKAK | HexNAc.Hex.NeuAc2 | 2600 | |
NL4-3 gp120 | 512.7 | 2 | 1023.4 | IEPLGVAPTK | Native peptide | 3840 |
695.2 | 2 | 1388.4 | IEPLGVAPTK | HexNAc.Hex | 6000 | |
840.6 | 2 | 1679.2 | IEPLGVAPTK | HexNAc.Hex.NeuAc | 4680 | |
986.1 | 2 | 1970.2 | IEPLGVAPTK | HexNAc.Hex.NeuAc2 | 180 | |
1023.1 | 2 | 2044.2 | IEPLGVAPTK | HexNAc2.Hex2.NeuAc | 400 | |
612.6 | 2 | 1223.2 | IEPLGVAPTKAK | Native peptide | 300 | |
940.2 | 2 | 1878.4 | IEPLGVAPTKAK | HexNAc.Hex.NeuAc | 250 | |
724.2 | 3 | 2169.6 | IEPLGVAPTKAK | HexNAc.Hex.NeuAc2 | 4100 | |
NL4-3 gp120+gp140 | 512.7 | 2 | 1023.4 | IEPLGVAPTK | Native peptide | 3900 |
695.2 | 2 | 1388.4 | IEPLGVAPTK | HexNAc.Hex | 1490 | |
840.9 | 2 | 1679.8 | IEPLGVAPTK | HexNAc.Hex.NeuAc | 250 | |
612.6 | 2 | 1223.2 | IEPLGVAPTKAK | Native peptide | 370 | |
940.2 | 2 | 1878.4 | IEPLGVAPTKAK | HexNAc.Hex.NeuAc | 100 | |
724.2 | 3 | 2169.6 | IEPLGVAPTKAK | HexNAc.Hex.NeuAc2 | Not Observed |
Electrospray Nano-LC-MS/MS summary showing the O-glycan occupancy of the conserved threonine of secreted HIV-1 YU2 gp120, HIV-1 JRCSF gp120, HIV-1 NL4-3 gp120 + gp140 mixture, HIV-1 YU2 gp120 + gp140. m/z is mass to charge ratio. MW is molecular weight. HexNAc.Hex is core 1. HexNAc.Hex.NeuAc is monosialylated core1. HexNAc.Hex.NeuAc2 is disialylated core 1. HexNAc2.Hex.2NeuAc is core 2.